223 related articles for article (PubMed ID: 9387899)
21. [Analysis of surgical treatment of papillary thyroid carcinoma].
Zhang ZM; Li ZJ; Tang PZ; Xu ZG; An CM
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):779-82. PubMed ID: 22335912
[TBL] [Abstract][Full Text] [Related]
22. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic central neck dissection in stage N0 papillary thyroid carcinoma.
Zuniga S; Sanabria A
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1087-91. PubMed ID: 19917919
[TBL] [Abstract][Full Text] [Related]
24. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
[TBL] [Abstract][Full Text] [Related]
25. [Papillary thyroid carcinoma: clinical manifestations, recurrences and prognosis].
Hay ID
Vestn Khir Im I I Grek; 2006; 165(1):43-5. PubMed ID: 16568855
[TBL] [Abstract][Full Text] [Related]
26. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
27. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
28. Recurrence and mortality in patients with differentiated thyroid carcinoma.
Noguchi M; Yagi H; Earashi M; Kinoshita K; Miyazaki I; Mizukami Y
Int Surg; 1995; 80(2):162-6. PubMed ID: 8530235
[TBL] [Abstract][Full Text] [Related]
29. Recommendation for subclass evaluation of TNM stage iva papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Ann Surg Oncol; 2008 May; 15(5):1511-7. PubMed ID: 18299932
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
[TBL] [Abstract][Full Text] [Related]
31. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
32. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of surgical treatment results in patients with differentiated thyroid cancer from materials in the Oncologic Institute in Gliwice].
Włoch J; Czarniecka A; Turska M; Wilgus J
Wiad Lek; 2001; 54 Suppl 1():178-88. PubMed ID: 12182023
[TBL] [Abstract][Full Text] [Related]
34. Local recurrence of papillary thyroid carcinoma after unilateral or bilateral thyroidectomy.
Grant CS; Hay D
Wien Klin Wochenschr; 1988 May; 100(11):342-6. PubMed ID: 3407192
[TBL] [Abstract][Full Text] [Related]
35. [The value of quantitative DNA analysis in evaluating the prognosis of differentiated thyroid cancer].
Böttger T; Potratz D; Schernus B; Klupp J; Stöckle M; Junginger T
Chirurg; 1994 Mar; 65(3):190-3. PubMed ID: 8194403
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic factors in patients with invasive differentiated thyroid carcinoma who underwent palliative resection].
Sugino K; Ito K; Mimura T; Ozaki O; Yamashita T; Kitamura Y; Iwabuchi H
Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1416-9. PubMed ID: 1280319
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in patients with differentiated thyroid carcinoma.
Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
[TBL] [Abstract][Full Text] [Related]
38. [One stage thyroidectomy and bilateral neck dissection for well-differentiated thyroid carcinoma].
Pan YF; Zhang XH; Ye GH; Lin BR; Chen XM; Jia XJ; Zhou SM; Wang OC
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):389-92. PubMed ID: 17045009
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic factors of papillary carcinomas of the thyroid gland--retrospective multivariate analysis of 227 patients with median follow-up 130 months].
Kure Y
Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1420-6. PubMed ID: 1448049
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.
Brierley J; Tsang R; Panzarella T; Bana N
Clin Endocrinol (Oxf); 2005 Oct; 63(4):418-27. PubMed ID: 16181234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
